May 5, 2023
RegMed Investors’ (RMi) closing bell: sentiment is overstretched yet, a solid Friday upside response
May 4, 2023
RegMed Investors’ (RMi) closing bell: sector barely wavers by earnings outcomes
May 1, 2023
RegMed Investors’ (RMi) closing bell: upside comes before it goes dark, or does it?
April 27, 2023
RegMed Investors’ (RMi) closing bell: the market moved up, the cell and gene therapy sector traveled with it
April 26, 2023
RegMed Investors’ (RMi) closing bell: Uncle algo showed briefly and left early
April 25, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector shillyshallies and then quivers
April 24, 2023
RegMed Investors’ (RMi) closing bell: calling the ball on underperforming share pricing, just too many factors to list
April 21, 2023
RegMed Investors’ (RMi) closing bell: the oversold cell and gene therapy sector was feeling the love
April 20, 2023
RegMed Investors’ (RMi) closing bell: the percentage downsizers are telling
April 19, 2023
RegMed Investors’ (RMi) closing bell: algorithms recognized the oversold
April 17, 2023
RegMed Investors’ (RMi) closing bell: sector share pricing rises after weeks of fear and dread
April 14, 2023
RegMed Investors’ (RMi) closing bell: understanding risk, be anticipatory and early
April 13, 2023
RegMed Investors’ (RMi) closing bell: sector more than gains following inflation data release
April 12, 2023
RegMed Investors’ (RMi) closing bell: CPI, a cooled rise of 0.1% in March
April 11, 2023
RegMed Investors’ (RMi) closing bell: a tug-of-war between sentiment and conviction as sector wavers and closes up
April 10, 2023
RegMed Investors’ (RMi) closing bell: sector hops back on the spinning tea cup amusement rides; but I am not entertained
April 5, 2023
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector just can’t get a break
April 4, 2023
RegMed Investors’ (RMi) closing bell: the pain trade
29 min ago
RegMed Investors (RMi) Closing Bell: A tug-of-war
9 hours 29 min ago
RegMed Investors’ (RMi) pre-open: Waiting the wait
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.